HomeProductsBrain & NervineKhameera Abresham Sada | 100 G...
Khameera Abresham Sada | 100 Gram | Ajmal
₨ 150
Khameera Abresham Sada is a cerebral and cardiac tonic, providing energy to the heart and brain, and alleviating restlessness, palpitation, and weakness. It improves eyesight, regulates cardiac beats, and eliminates perplexity and restlessness. This Unani Tibb herbal remedy treats flu, dyspnea, asthma, general debility, and high blood pressure. Benefits include cerebral and cardiac toning, improved eyesight, normalized cardiac beats, relief from weakness, syncope, general debility, dyspnea, asthma, and high blood pressure.
2 in stock
- Cerebral and cardiac tonic
- Helpful in restlessness and palpitation
- Improves eyesight
- Regulates and normalize the cardiac beats
- Eliminates perplexity and restlessness from the body
- Relieves weakness after illness and syncope
- Removes general debility
- Treats dyspnea
- Alleviate asthmatic symptoms
- Normalizes high blood pressure
- Keep the medicine out of children reach.
- Consult with physician first. Self-medication is not recommended.
Ajmal Khameera Abresham Sada
Khameera Abresham Sada is a cerebral and cardiac tonic, provides energy to heart and brain. In Unani Tibb, it is considered an effective cerebral and cardiac herbal remedy.
Uses
It is also helpful in restlessness and palpitation. It improves eyesight. it is also helpful to regulate and normalize the cardiac beats.
It provides help potentiates the vital organs and eliminates perplexity and restlessness from the body. it is also helps to relieve weakness after illness and syncope.
Other therapeutic uses of Khameera Abresham Sada include flu, dyspnoea, asthma, general debility, as well as for high blood pressure treatment.
SYMPTOMS / TREATMENT
INDICATIONS
INGREDIENTS
Abresham Muqarraz (Bombax mori)
DOSAGE
5 g with water two times a day or as directed by the physician.
Weight | 0.166 kg |
---|---|
Packing |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.